There is no evidence that Repaglinide Tablets are dialyzable using hemodialysis.
Repaglinide exposure is increased in patients with hepatic insufficiency and in the elderly type 2 diabetic patients.
Repaglinide, like other insulin secretagogues, is capable of producing hypoglycaemia.
Adverse effects have been reported in some animal studies. Repaglinide metabolites do not possess appreciable hypoglycemic activity.
Other medications can affect the removal of repaglinide from your body, which may affect how repaglinide works. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
A governmentally-recognized ID which uniquely identifies the product within its regulatory market.
Ask your doctor before use if you are taking the following medications:
It might be best to stop drinking alcohol until you see how the medicine makes you feel.
See full prescribing information for complete boxed warning.
It is recommended that patients under medication for diabetes mellitus be carefully monitored.
Drug interaction studies performed in healthy volunteers show that Repaglinide Tablets had no clinically relevant effect on the pharmacokinetic properties of digoxin, theophylline, or warfarin. You should https://thectrforpsychotherapy.com/antibacterial/cefixime-trihydrate-100-mg.php consult your doctor about your diabetes treatment if you are due to have surgery under a general anaesthetic, or if you get pregnant.
For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist. This company also manufactures NovoRapid, Human Mixtard, NovoMix 30 and other insulin preparations which are in widespread use. Psoriasis See What It Looks Like and How to Treat It.
You are encouraged to report negative side effects of prescription drugs to the FDA.